» Articles » PMID: 34210791

Cardiopulmonary Exercise Capacity and Limitations 3 months After COVID-19 Hospitalisation

Overview
Journal Eur Respir J
Specialty Pulmonary Medicine
Date 2021 Jul 2
PMID 34210791
Citations 87
Authors
Affiliations
Soon will be listed here.
Abstract

Background: This study aimed to describe cardiopulmonary function during exercise 3 months after hospital discharge for COVID-19 and compare groups according to dyspnoea and intensive care unit (ICU) stay.

Methods: Participants with COVID-19 discharged from five large Norwegian hospitals were consecutively invited to a multicentre, prospective cohort study. In total, 156 participants (mean age 56.2 years, 60 females) were examined with a cardiopulmonary exercise test (CPET) 3 months after discharge and compared with a reference population. Dyspnoea was assessed using the modified Medical Research Council (mMRC) dyspnoea scale.

Results: Peak oxygen uptake (' ) <80% predicted was observed in 31% (n=49). Ventilatory efficiency was reduced in 15% (n=24), while breathing reserve <15% was observed in 16% (n=25). Oxygen pulse <80% predicted was found in 18% (n=28). Dyspnoea (mMRC ≥1) was reported by 47% (n=59). These participants had similar ' (p=0.10) but lower mean±sd ' ·kg % predicted compared with participants without dyspnoea (mMRC 0) (76±16% 89±18%; p=0.009) due to higher body mass index (p=0.03). For ICU- non-ICU-treated participants, mean±sd ' % predicted was 82±15% and 90±17% (p=0.004), respectively. Ventilation, breathing reserve and ventilatory efficiency were similar between the ICU and non-ICU groups.

Conclusions: One-third of participants experienced ' <80% predicted 3 months after hospital discharge for COVID-19. Dyspnoeic participants were characterised by lower exercise capacity due to obesity and lower ventilatory efficiency. Ventilation and ventilatory efficiency were similar between ICU- and non-ICU-treated participants.

Citing Articles

The impact of COVID-19 severity on adult survivors: Is there a relationship between vascular reactivity and cardiorespiratory fitness?.

Back G, Oliveira M, Areas G, Camargo P, da Luz Goulart C, de Oliveira C Physiol Rep. 2025; 13(5):e70216.

PMID: 40025655 PMC: 11872806. DOI: 10.14814/phy2.70216.


Association of Pulmonary Involvement at Baseline with Exercise Intolerance and Worse Physical Functioning 8 Months Following COVID-19 Pneumonia.

Uzel F, Peker Y, Atceken Z, Karatas F, Atasoy C, Caglayan B J Clin Med. 2025; 14(2.

PMID: 39860481 PMC: 11765862. DOI: 10.3390/jcm14020475.


Maximal oxygen uptake, pulmonary function and walking economy are not impaired in patients diagnosed with long COVID.

Berg O, Aagard N, Helgerud J, Brobakken M, Hoff J, Wang E Eur J Appl Physiol. 2024; .

PMID: 39611942 DOI: 10.1007/s00421-024-05652-7.


Effects of a cardiopulmonary rehabilitation programme on submaximal exercise in Tunisian patients with long-COVID19: A randomized clinical trial.

Kaddoussi R, Rejeb H, Kalai A, Zaara E, Rouetbi N, Frih Z Biol Sport. 2024; 41(4):197-217.

PMID: 39416495 PMC: 11474993. DOI: 10.5114/biolsport.2024.139072.


Towards an understanding of physical activity-induced post-exertional malaise: Insights into microvascular alterations and immunometabolic interactions in post-COVID condition and myalgic encephalomyelitis/chronic fatigue syndrome.

Haunhorst S, Dudziak D, Scheibenbogen C, Seifert M, Sotzny F, Finke C Infection. 2024; 53(1):1-13.

PMID: 39240417 PMC: 11825644. DOI: 10.1007/s15010-024-02386-8.


References
1.
Wiersinga W, Rhodes A, Cheng A, Peacock S, Prescott H . Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020; 324(8):782-793. DOI: 10.1001/jama.2020.12839. View

2.
Gulati M, Black H, Shaw L, Arnsdorf M, Merz C, Lauer M . The prognostic value of a nomogram for exercise capacity in women. N Engl J Med. 2005; 353(5):468-75. DOI: 10.1056/NEJMoa044154. View

3.
Parshall M, Schwartzstein R, Adams L, Banzett R, Manning H, Bourbeau J . An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med. 2012; 185(4):435-52. PMC: 5448624. DOI: 10.1164/rccm.201111-2042ST. View

4.
Belli S, Balbi B, Prince I, Cattaneo D, Masocco F, Zaccaria S . Low physical functioning and impaired performance of activities of daily life in COVID-19 patients who survived hospitalisation. Eur Respir J. 2020; 56(4). PMC: 7411272. DOI: 10.1183/13993003.02096-2020. View

5.
Stanojevic S, Graham B, Cooper B, Thompson B, Carter K, Francis R . Official ERS technical standards: Global Lung Function Initiative reference values for the carbon monoxide transfer factor for Caucasians. Eur Respir J. 2017; 50(3). DOI: 10.1183/13993003.00010-2017. View